Naltrexone Treatment Centers in Maine

For methadone and buprenorphine, continued opioid use during induction is common and expected; the medication itself helps stop use. For naltrexone, however, you must complete a 7–14 day opioid-free period first. Your Maine clinician will tailor the induction based on your medication.

Most Maine programs include routine urine drug screens in the program fee. Baseline lab work (liver function, pregnancy test, ECG for methadone) may be billed separately — $30–$150 depending on insurance status. Ask about lab fees at intake.

Yes — MaineCare can pay retroactively for up to 3 months of prior treatment in most cases, provided you were eligible during that period. Save all receipts and itemized statements from naltrexone providers and submit them to the Medicaid enrollment caseworker.

Yes. Blue Cross Blue Shield plans in Maine cover all three FDA-approved MAT medications. BCBS typically requires the provider to be in-network; most major naltrexone providers in Portland and across Maine accept BCBS.

Yes — federal Congress eliminated the X-waiver in December 2022, so any Maine clinician with a DEA registration can now prescribe buprenorphine for OUD. Continuing-education requirements apply; training is free through Providers Clinical Support System (PCSS) and SAMHSA.

Yes. Buprenorphine and naltrexone prescriptions travel with you. For methadone, your clinic coordinates with an out-of-state guest-dosing OTP; plan at least 2 weeks ahead for domestic travel, longer for international. Ask the clinic about guest-dosing letters.

Yes. Transferring to a different Maine provider is routine; the new clinic will request records with your consent and continue your current dose. There is no penalty for switching providers — clinical compatibility matters.

Expect questions about your substance use history, overdose history, medical and mental-health conditions, current medications, pregnancy risk, social support, housing, legal status, and treatment goals. Answers help tailor the plan — honesty produces better clinical care, and answers are protected under 42 CFR Part 2.

Methadone can prolong the QTc interval on ECG; Maine clinics screen patients with baseline and follow-up ECGs. Buprenorphine and naltrexone do not carry this risk. Patients with cardiac disease can safely use MAT under close cardiology and MAT-team coordination.

Methadone doses often need increase in the third trimester due to increased metabolism; split dosing may be needed. Buprenorphine sometimes requires modest increases. Your Maine MAT team and OB will monitor closely and adjust dosing based on cravings and withdrawal.

Common options include cognitive-behavioral therapy, motivational interviewing, contingency management, group counseling, and trauma-focused therapy. Many Maine programs also offer peer-recovery support. The clinical team matches you with the modality most aligned to your goals.

Life-insurance applications typically ask about current medications and substance-use history. Failing to disclose can void a policy. Some insurers rate MAT neutrally for stable long-term patients; shop among carriers and consider no-medical-exam policies if rates are unfavorable.